Search clinical trials for: programmed cell death receptor 1 (PD-1)
Total 104076 results
-
Chinese PLA General HospitalRecruitingHodgkin Lymphoma | Anti-PD-1 Antibody ResistantChina
-
Peking Union Medical College HospitalUnknownAdvanced Colorectal CarcinomaChina
-
Incyte CorporationMerck Sharp & Dohme LLCActive, not recruitingHead and Neck CancerCanada, Spain, Korea, Republic of, United States, Austria, Japan, United Kingdom, Taiwan, Italy, Hungary, Australia, Turkey, Poland, Portugal
-
Merck Sharp & Dohme LLCActive, not recruitingMelanomaUnited States, Australia, France, Israel, Italy, Switzerland
-
CONRADNational Institute of Allergy and Infectious Diseases (NIAID); Eunice Kennedy... and other collaboratorsCompletedPharmacokinetics of 1% Tenofovir Gel Following Coitus | Pharmacodynamics of 1% Tenofovir Gel Following CoitusUnited States
-
Gazi UniversityHacettepe University; Cukurova University; Marmara University; Istanbul University and other collaboratorsUnknownEnteral Nutrition | Feeding Intolerance | Intestinal Fatty Acid Binding ProteinGermany
-
Hunan Province Tumor HospitalRecruitingNon Small Cell Lung CancerChina
-
The First Affiliated Hospital with Nanjing Medical...RecruitingBladder Urothelial CarcinomaChina
-
Greg Durm, MDMerck Sharp & Dohme LLC; Big Ten Cancer Research ConsortiumCompleted
-
Sumitomo Pharma Co., Ltd.Completed
-
Ningbo No. 1 HospitalRecruiting
-
Ningbo No. 1 HospitalRecruiting
-
Ningbo No. 1 HospitalNot yet recruitingNonalcoholic Fatty Liver DiseaseChina
-
Ningbo No. 1 HospitalCompletedParoxysmal Supraventricular TachycardiaChina
-
Ningbo No. 1 HospitalUnknownBowel PreparationChina
-
Ningbo No. 1 HospitalCompletedMetabolic Associated Fatty Liver Disease
-
Ningbo No. 1 HospitalCompleted
-
University of Yaounde 1UnknownSurgery | Anesthesia | Clinical Trial | Gynecology | OpioidsCameroon
-
Ningbo No. 1 HospitalUnknown
-
University of Oran 1CompletedGeneral Surgery | Cholecystectomy | Practice Guidelines as Topic
-
Ningbo No. 1 HospitalUnknown
-
Ningbo No. 1 HospitalCompleted
-
Ningbo No. 1 HospitalCompletedNonalcoholic Fatty Liver Disease | Type2 Diabetes Mellitus | Light-to-moderate Alcohol ConsumptionChina
-
Ningbo No. 1 HospitalCompleted
-
Cancer Hospital of Guangxi Medical UniversityRecruitingNasopharyngeal Carcinoma | SintilimabChina
-
Sichuan UniversityRecruitingNSCLC | PD-1 Inhibitor | Leptomeningeal Metastasis | Low Dose RadiotherapyChina
-
Peking UniversityRecruitingHepatocellular Carcinoma | Portal Vein ThrombosisChina
-
Elpiscience Biopharma, Ltd.Shanghai Junshi Bioscience Co., Ltd.RecruitingNeoplasms | Solid Tumor | Malignant TumorChina
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityRecruitingBreast Cancer | Triple-Negative Breast CancerChina
-
Fukushima Medical UniversityKanagawa Cancer CenterUnknown
-
Jiangsu HengRui Medicine Co., Ltd.Active, not recruitingChemotherapy Effect | Lung Cancer Stage IV | PD-1 Antibody | Lung Cancer Squamous CellChina
-
Fuzhou General HospitalUnknownSmall Cell Lung Cancer | Lung Neoplasm | PD-1 InhibitorsChina
-
Novartis PharmaceuticalsCompletedMelanoma | Triple Negative Breast Cancer | Anaplastic Thyroid Cancer | Other Solid Tumors | Non-small Sell Lung Cancer (NSCLC)United States, Italy, Spain, Hungary, Taiwan, Germany, Netherlands, France, Norway, Poland, Thailand, Lebanon, Turkey, Canada
-
Ondokuz Mayıs UniversityHacettepe UniversityRecruitingCerebral Palsy | Chewing Disease | Action Obervation TrainingTurkey
-
Kirsehir Ahi Evran UniversitesiNot yet recruiting
-
Southwest Hospital, ChinaUnknownCholelithiasis | CholangiojejunostomyChina
-
The Affiliated Hospital of Qingdao UniversityUnknown
-
Ascendis Pharma Oncology Division A/SRecruitingAdvanced Solid Tumor | Metastatic Solid Tumor | Platinum-resistant Ovarian Cancer | Locally Advanced Solid Tumor | Post Anti-PD-1 Melanoma | 2L+ Cervical Cancer | Neoadjuvant Melanoma | Neoadjuvant Non-Small Cell Lung Cancer | Post Anti-PD-(L)1 Non-Small Cell Lung Cancer | Post Anti-PD-(L)1 Small Cell...United States, Australia, Korea, Republic of
-
Queensland Centre for Gynaecological CancerGlaxoSmithKline Research & Development LimitedNot yet recruitingMmr Deficiency | Endometrial Cancer Stage I | Immune-related Adverse Event | Endometrioid Endometrial AdenocarcinomaAustralia
-
Northwestern UniversityNational Cancer Institute (NCI)RecruitingLocally Advanced Thyroid Gland Anaplastic Carcinoma | Metastatic Thyroid Gland Anaplastic Carcinoma | Metastatic Thyroid Gland Oncocytic CarcinomaUnited States
-
Fundacion para la Investigacion Biomedica del Hospital...PfizerCompleted
-
Second Affiliated Hospital of Soochow UniversityNot yet recruiting
-
Japan Clinical Oncology GroupMinistry of Health, Labour and Welfare, JapanCompletedOvarian Neoplasms | Fallopian Tube Neoplasms | Peritoneal NeoplasmsJapan
-
Shimousa Hematology Study GroupEpidemiological and Clinical Research Information NetworkUnknown
-
Taiho Pharmaceutical Co., Ltd.Completed
-
Japan Clinical Oncology GroupMinistry of Health, Labour and Welfare, JapanTerminated
-
Pyrotech Therapeutics, Inc.RecruitingLocally Advanced or Metastatic Solid TumorsUnited States
-
Peking University First HospitalYiZhou International Cancer HospitalUnknownImmunotherapy | Proton Therapy
-
Beijing Friendship HospitalCompletedCamrelizumab Combined With Apatinib and Capecitabine in Patients With Advanced Biliary Tract Cancer.Biliary Tract Cancer | Capecitabine | Targeted Molecular Therapy | Anti-PD-1 TherapyChina